Abstract
Therapy for mitral regurgitation (MR) has been synonymous with mitral valve surgery. Operative approaches for degenerative MR repair have been associated with excellent results, with durable long term outcomes. Surgery for functional MR has been less successful. MitraClip has shown promise for functional MR, especiall in patinets who are high risk for surgery. The aggregate of nonrandomized global experience with MitraClip in functional MR has been consistent in showing improvements in symptoms and left ventricular remodeling. It remains to be seen how MitraClip therapy will compare with best medical therapy. The COAPT trial will clarify this question.
Original language | English (US) |
---|---|
Pages (from-to) | 83-91 |
Number of pages | 9 |
Journal | Interventional Cardiology Clinics |
Volume | 5 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2016 |
Keywords
- COAPT
- Functional mitral regurgitation
- MitraClip
- Mitral regurgitation
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine